The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring ...
The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
The community walks with Alzheimer's Association to raise funds that will go towards advancement for research in a cure.
Could disrupting your internal clock be the key to treating Alzheimer’s? A surprising new study, published in the journal ...
A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...
Since 2013, for the Walk to End Alzheimer’s, the “Jevning Gems” team, led by Val Blomquist of Hallock, Minnesota, has raised $262,500 for research, education and resources ...
In recognition of Alzheimer’s Awareness Month, the Centers for Medicare and Medicaid Services should review and revise policies for Alzheimer’s disease therapies to clear the path for early ...
Researchers used supramolecular nanoparticles to repair the brain’s vascular system and reverse Alzheimer’s in mice. Instead ...
Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...
The 2025 Walk to End Alzheimer’s is moving to the Maryland Zoo, bringing families, caregivers, and survivors together to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback